Time once again for an overheated pitch from our friend Louis Navellier… he’s been circulating ads for his Emerging Growth newsletter ($695/yr) that promote several of his favorite ideas for the year ahead, including a rehash of his lithium pick from a few months ago as well as this newer (to me, at least) “World’s […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
That's what I'm seeing on the CDC site too - diabetes. And Eli Lilly bought a glucagon nasal spray from a small company ...